Document Detail

Retinoid receptors in gastric cancer: expression and influence on prognosis.
MedLine Citation:
PMID:  22901127     Owner:  NLM     Status:  In-Data-Review    
Background: Gastric cancer is frequently lethal despite aggressive multimodal therapies, and new treatment approaches are therefore needed. Retinoids are potential candidate drugs: they prevent cell differentiation, proliferation and malignant transformation in gastric cancer cell lines. They interact with nuclear retinoid receptors (the retinoic acid receptors [RARs] and retinoid X receptors [RXRs]), which function as transcription factors, each with three subclasses, α, β and γ. At present, little is known about retinoid expression and influence on prognosis in gastric cancers. Patients and Methods: We retrospectively analyzed the expression of the subtypes RARα, RARβ, RARγ, RXRα, RXRβ, RXRγ by immunohistochemistry in 147 gastric cancers and 51 normal gastric epithelium tissues for whom clinical follow-up data were available and correlated the results with clinical characteristics. In addition, we quantified the expression of retinoid receptor mRNA using real- time PCR (RT-PCR) in another 6 gastric adenocarcinoma and 3 normal gastric tissues. From 2008 to 2010, 80 patients with gastric cancers were enrolled onto therapy with all-trans-retinoic acid (ATRA). Results: RARα, RARβ, RARγ and RXRγ positively correlated with each other (p < 0.001) and demonstrated significantly lower levels in the carcinoma tissue sections (p < 0.01), with lower RARβ, RARγ and RXRα expression significantly related to advanced stages (p < =0.01). Tumors with poor histopathologic grade had lower levels of RARα and RARβ in different histological types of gastric carcinoma (p < 0.01). Patients whose tumors exhibited low levels of RARa expression had significantly lower overall survival compared with patients who had higher expression levels of this receptor (p < 0.001, HR=0.42, 95.0% CI 0.24-0.73), and patients undergoing ATRA treatment had significantly longer median survival times (p = 0.007, HR=0.41, 95.0% CI 0.21-0.80). Conclusions: Retinoic acid receptors are frequently expressed in epithelial gastric cancer with a decreased tendency of expression and RARa may be an indicator of a positive prognosis. This study provides a molecular basis for the therapeutic use of retinoids against gastric cancer.
Kong-Wang Hu; Fei-Hu Chen; Jin-Fang Ge; Li-Yu Cao; Hao Li
Related Documents :
22414547 - Decreased expression of t-cadherin is associated with gastric cancer prognosis.
11382597 - Gene therapy of metastatic disease: progress and prospects.
8137337 - Pharmacokinetics and cancer: successes, failures and future prospects.
11899327 - Pharmacologic and biologic therapies in cancer care: part ii.
24460357 - Methylation profile of brca1, rassf1a and er in vietnamese women with ovarian cancer.
19446867 - Anaphylactic shock during the sentinel lymph node procedure for cervical cancer.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Asian Pacific journal of cancer prevention : APJCP     Volume:  13     ISSN:  1513-7368     ISO Abbreviation:  Asian Pac. J. Cancer Prev.     Publication Date:  2012  
Date Detail:
Created Date:  2012-08-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101130625     Medline TA:  Asian Pac J Cancer Prev     Country:  Thailand    
Other Details:
Languages:  eng     Pagination:  1809-17     Citation Subset:  IM    
Department of General Surgery, the First Hospital of Anhui Medical University, Hefei, China E-mail :
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  hOGG1, p53 Genes, and Smoking Interactions are Associated with the Development of Lung Cancer.
Next Document:  Acute Effects of Dokha Smoking on the Cardiovascular and Respiratory Systems among UAE Male Universi...